7 analysts have shared their evaluations of Health Catalyst (NASDAQ:HCAT) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 5 | 0 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 1 | 4 | 0 | 0 | 0 |
3M Ago | 1 | 0 | 0 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $13.14, a high estimate of $16.00, and a low estimate of $10.00. This current average reflects an increase of 1.08% from the previous average price target of $13.00.
Decoding Analyst Ratings: A Detailed Look
A clear picture of Health Catalyst's perception...
Login or create a forever free account to read this news
Sign up/Log in